Peru approves medicinal use of marijuana

October 20, 2017 12:56 pm | Updated 12:56 pm IST - Lima:

 In this September 15, 2017 file photo, a venture capital booth is seen at the Cannabis World Congress and Business Exposition, a trade show for the legalized adult use, medical marijuana and industrial hemp industries, in Los Angeles, California, U.S.

In this September 15, 2017 file photo, a venture capital booth is seen at the Cannabis World Congress and Business Exposition, a trade show for the legalized adult use, medical marijuana and industrial hemp industries, in Los Angeles, California, U.S.

The Peruvian Congress has approved a bill that authorises the medicinal and therapeutic use of cannabis and its derivatives in the country.

The proposal received 67 votes against five as three abstained in a full legislative on Thursday, allowing the bill to be enacted by the executive without going through the second voting session as required by law.

The bill will legalise the medicinal use of marijuana and its derivatives, such as cannabis oil, to alleviate the symptoms of diseases such as cancer, epilepsy and Parkinson’s disease, Efe news reported.

Congressman Alberto de Belaunde, who was the advocate of the proposal, said that once the bill is promulgated the government will have 60 days to work on the regulations.

Mr. De Belaunde added that this document must be published in advance so that all citizens will have access to its content and send suggestions and proposals.

“We achieved it. Historic moment for Congress and the country: Legal medicinal cannabis,” Mr. De Belaunde wrote on his Twitter account.

The legislative approval came following the government’s proposal to decriminalise the medical use of marijuana, following a “controversial” raid in February at a clandestine laboratory where marijuana oil was manufactured for sick children.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.